Brief: Active Biotech appoints Helen Tuvesson as new CEO
June 19 (Reuters) - Active Biotech Ab ACTI.ST
* the Board has appointed the company's current CSO Helén
Tuvesson as new CEO of Active Biotech AB
* Tuvesson will take up the position on July 1
* Tomas Leanderson, CEO since 2008, will be at the
company's disposal during a transitional period
Source text for Eikon: ID:nGNE5QTqwD
Further company coverage: ACTI.ST
(Reporting By Anna Ringstrom)
((Anna.Ringstrom@thomsonreuters.com;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million